Bharat Biotech acquired Chiron Behring from GSK in March this year and commercial operations at the company's Ankleshwar (Gujarat) unit restarted in May.
So far there are no vaccines in the world against Zika and Chikungunya.
The acquisition allows Hyderabad-headquartered Bharat Biotech to become world's largest manufacturer of rabies vaccines.
World Health Organisation (WHO) prequalification is necessary for the UN agencies and Gavi, the Vaccine Alliance to purchase vaccines in partnership with developing countries.
Bharat Biotech said it got approval for phase-1 clinical trial from Indian regulator Drug Controller General of India DCG(I) in 2016 after successful completion of product development and pre-clinical testing of its vaccine candidate.
The mosquito-transmitted Zika virus, which has the world on edge because of its newly-acquired pandemic status, may now have a cure â€“ a vaccine that's the first of its kind in the world.
The virus is spreading rapidly in the Americas, and WHO officials on Tuesday expressed concern that it could hit Africa and Asia as well. No vaccine has been developed so far.
India is ahead of other EMs in innovation: Rogerio
The Government of India‘s Department of Biotechnology (DBT) and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India.
Hyderabad, Jun 6 (PTI) Bharat Biotech, a city-based biotechnology company today set the price of its indigenously developed Rotavirus diarrhoea vaccine, Rotavac at USD one.
Big pharma is looking for immunity from a fall in revenues as blockbuster drugs go off patent. They are finding it in Indian vaccine makers